Association of the carriage of IL-1B rs1143634 and rs16944 polymorphisms and BDNF rs6265 polymorphism with temporal lobe epilepsy
https://doi.org/10.14412/2074-2711-2019-2-46-51
Abstract
Temporal lobe epilepsy (TLE) is one of the most common and refractory forms of epilepsy, which has different etiologies. Experimental and clinical studies have demonstrated that transformation of the normal brain neuron activity pattern into paroxysmal one is accompanied by changes in the expression of cytokines and neurotrophins in the hippocampus and temporal cortex. Modulation of the expression of brainderived neurotrophic factor (BDNF) may be associated with the carriage of the single nucleotide polymorphism (SNP) rs6265 in the BDNF gene. Groups of investigators have shown the increased expression of BDNF in the hippocampus and temporal cortex of patients with drugresistant epilepsy. Independent studies have demonstrated the role of the IL-1B gene encoding the proinflammatory cytokine interleukin (IL) 1in the development of inflammatory responses and structural mediobasal TLE with hippocampal sclerosis.
Objective: to study the association of the carriage of the SNPs rs16944 and rs1143634 in the IL-1B gene and rs6265 in the BDNF gene with the development of TLE.
Patients and methods. Real-time polymerase chain reaction was used to conduct a molecular genetic study of the carriage of the SNPs rs1143634 and rs16944 in the IL-1B gene and rs6265 in the BDNF gene in 84 patients with TLE and in 203 healthy Caucasian volunteers, who lived in the Siberian Federal District.
Results and discussion. The carriage of the high-producing C allele (odds ratio (OR)=2.01; 95% confidence interval (CI), 1.31–3.08; p=0.001) and the homozygous CC genotype (OR=2.48; 95% CI, 1.47–4.17; p=0.001) of SNP rs1143634 in the IL-1B gene was found to be statistically significantly associated with the development of TLE in the examined population. There were no statistically significant differences in the carriage of the SNPs rs1143634 and rs16944 in the IL-1B gene and rs6265 in the BDNF gene with the clinical presentations and course of TLE (p>0.05). The carriage of the SNP rs6265 in the BDNF gene was ascertained to be unassociated with the development of TLE (2=0.3; p =0.86).
Conclusion. The authors have established an association of the carriage of the high-producing C allele and the homozygous CC genotype of the SNP rs1143634 in the IL-1B gene with TLE.About the Authors
Yu. S. PaninaRussian Federation
Yulia Sergeevna Panina
1, Partisan Zheleznyak St., Krasnoyarsk 660022
D. V. Dmitrenko
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022
N. A. Shnaider
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, 3, Bekhterev St., Saint Petersburg 192019
E. V. Egorova
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022
A. A. Usoltseva
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022
References
1. Mukhin KYu, Gataullina SKh, Petrukhin AS. Paleocortical temporal lobe epilepsy caused by mesial temporal sclerosis: clinical features, diagnosis and treatment (review of literature). Russkii zhurnal detskoi nevrologii. 2008;3(3): 41-60. (In Russ.).
2. Dmitrenko DV, Stroganova MA, Shnaider NA, et al. Histological classification of mesial temporal sclerosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):74-9. (In Russ.). Doi: 10.14412/2074-2711-2016-2-74-79
3. Rijkers K, Majoie HJ, Hoogland G. The role of interleukin-1 in seizures and epilepsy: A critical review. Behav Sci (Basel). 2018 Feb;8(2):21. doi: 10.3390/bs8020021.
4. Martinez-Levy GA, Rocha L, Rodriguez-Pineda F, et al. Increased expression of Brain-Derived Neurotrophic Factor transcripts I and VI, cAMP response element binding, and glucocorticoid receptor in the cortex of patients with temporal lobe epilepsy. Mol Neurobiol. 2018 May;55(5):3698-3708. doi: 10.1007/s12035-017-0597-0. Epub 2017 May 19.
5. Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016 Feb;131(2):211-234. doi: 10.1007/s00401-015-1481-5. Epub 2015 Sep 30.
6. Kauffman MA, Moron DG, Consalvo D. Association study between interleukin 1В gene and epileptic disorders: a HuGe review and meta-analysis. Genetics In Medicine. 2008; 10(2): 83-8.
7. Terskova NV, Vakhrushev SG, Simbirtsev AS, et al. Allelic polymorphism of interleukin-1 beta gene in proband children with chronic adenoiditis, healthy children, their respondentsrelatives. Sibirskoe meditsinskoe obozrenie. 2015; (6):12-7. (In Russ.).
8. Shnaider NA, Martynova GP, Stroganova MA, et al. Febrile seizures as a trigger of mesial temporal sclerosis: a clinical case. Problemy zhenskogo zdorov'ya. 2015;10(1):69-78. (In Russ.).
9. Stroganova MA, Dmitrenko DV, Artyukhov IP, et al. Association Between IL1B and SCN1A Polymorphism and Febrile Seizures in Children in Siberia. International Journal of Biomedicine. 2017;7(2):96-103
10. Diamond ML, Ritter AC, Failla MD, et al. IL1b associations with posttraumatic epilepsy development: A genetics and biomarker cohort study. Epilepsia. 2014 Jul;55(7):1109-19. doi: 10.1111/epi.12628. Epub 2014 Apr 22.
11. Shen N, Zhu X, Lin H, et al. Role of BDNF Val66Met functional polymorphism in temporal lobe epilepsy. Int J Neurosci. 2016; 126(5):436-41. doi: 10.3109/00207454.2015.1026967. Epub 2015 Aug 18.
12. Wahab A. Difficulties of treatment and management of epilepsy and challenges of new drug development. Pharmaceuticals (Basel). 2010 Jul 5;3(7):2090-2110. doi: 10.3390/ph3072090.
13. Aronica E, Gorter JA, Ramkema M, et al. Expression and cellular distribution of multidrug resistance-relatedproteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia. 2004 May;45(5):441-51. doi: 10.1111/j.0013-9580.2004.57703.x.
14. Bernardino L, Ferreira R, Cristovao AJ, et al. Inflammation and neurogenesis in temporal lobe epilepsy. Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):349-60.
15. Leal B, Chaves J, Carvalho C, et al. Brain expression of inflammatory mediators in mesial temporal lobe epilepsy patients. J Neuroimmunol. 2017 Dec 15;313:82-88. doi: 10.1016/j.jneuroim.2017.10.014. Epub 2017 Nov 6.
16. Uludag I, Duksal T, Tiftikcioglu B, et al. IL-1, IL-6 and IL1Ra levels in temporal lobe epilepsy. Seizure. 2015 Mar;26:22-5. doi: 10.1016/j.seizure.2015.01.009. Epub 2015 Jan 21.
17. Lipatova LV, Serebryanaya NB, Sivakova NA. The role of neuroinflammation in the pathogenesis of epilepsy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1S): 38-45. (In Russ.). doi:10.14412/2074-27112018-1S-38-45.
18. Gromova AYu, Simbirtsev AS. Gene polymorphism of the human IL-1 genes. Tsitokiny i vospalenie. 2005;4(2):3-12. (In Russ.)
19. Salzmann A, Lambercy C, Malafosse A. Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci. 2008 Dec;29(6): 397-403. doi: 10.1007/s10072-008-1060-9. Epub 2008 Dec 6.
20. Salzmann A, Malafosse A. Genetics of temporal lobe epilepsy: a review. Epilepsy Res Treat. 2012;2012:863702. doi: 10.1155/2012/863702. Epub 2012 Feb 19.
21. Leal B, Chaves J, Carvalho С. Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis. Int J Neurosci. 2017 Jul;28(4):1-16. doi: 10.1080/00207454.2017.1349122.15.
22. Lehtimд ki KA, Kerд nen T, Palmio J, et al. Levels of IL-1beta and IL-1RA in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroimmunomodulation. 2010;17(1):19-22. doi: 10.1159/000243081. Epub 2009 Oct 5.
23. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736. doi: 10.1146/annurev.neuro.24.1.677.
24. De Souza Bernardino TC, Teixeira AL, Miranda AS, et al. Wistar audiogenic rats (WAR) exhibit altered levels of cytokines and brain-derived neurotrophic factor following audiogenic seizures. Neurosci Lett. 2015 Jun 15; 597:154-8. doi: 10.1016/j.neulet.2015.04.046. Epub 2015 Apr 30.
25. LaFrance WC Jr, Leaver K, Stopa EG, et al. Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures. Neurology. 2010 Oct 5;75(14):1285–1291. doi: 10.1212/WNL.0b013e3181f612bb
26. Isackson PJ, Huntsman MM, Murray KD, et al. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron. 1991 Jun;6(6):937-48.
27. Karnik MS, Wang L, Barch DM, et al. BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Res. 2010 Jul; 178(2): 425-9. doi: 10.1016/j.psychres.2009.09.008. Epub 2010 May 20.
28. Yue-Long Xu, Xiu-Xiu Li, Su-Jing Zhuang et al. Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis. Neuropsychiatr Dis Treat. 2018 Apr 16;14:1035-1046. doi: 10.2147/NDT.S154927. eCollection 2018.
29. Fu L, Luo C, Su B, et al. Study on the correlation between BDNF gene polymorphism and patients with temporal lobe epilepsy. Neuropsychiatr Dis Treat. 2018;14:1035–46. doi:10.2147/NDT.S154927.
30. Alcantara J, Vincentiis S, Kerr D. BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population. Seizure. 2018 Aug;7(60):159-62. Epub 2018 Jul 7.